Cargando…
Drug target of natural products and COVID-19: how far has science progressed?
The new coronavirus [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] that caused a viral disease with a high risk of mortality (coronavirus disease 2019) was found toward the end of 2019. This was a significant acute respiratory syndrome. In a brief period, this virus spread throughout...
Autores principales: | Raman, Kannan, Rajagopal, Kalirajan, Ramesh, B., Nallasivan, P. Kumar, Raja, M. K. Mohan M., Jupudi, Srikanth, Byran, Gowramma, Khan, Sharuk L., Bin Emran, Talha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289732/ https://www.ncbi.nlm.nih.gov/pubmed/37363478 http://dx.doi.org/10.1097/MS9.0000000000000703 |
Ejemplares similares
-
Identification of Papain-Like Protease inhibitors of SARS CoV-2 through HTVS, Molecular docking, MMGBSA and Molecular dynamics approach
por: Jupudi, Srikanth, et al.
Publicado: (2022) -
Role of natural products towards the SARS-CoV-2: A critical review
por: Raman, Kannan, et al.
Publicado: (2022) -
Acridine as an Anti-Tumour Agent: A Critical Review
por: Varakumar, Potlapati, et al.
Publicado: (2022) -
Activity of phytochemical constituents of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): an in silico approach
por: Rajagopal, Kalirajan, et al.
Publicado: (2020) -
Autophagy and Alzheimer’s disease: How far science has to be progressed? − correspondence
por: Emran, Talha B., et al.
Publicado: (2023)